evorel 50mcg/24h transdermal patch
janssen-cilag international nv (0000003494) turnhoutseweg, 30, beerse, b-2340 - estradiol - transdermal patch - 50mcg/24h - estradiol (0000050282) 3.2mg - estradiol
pariet 20mg gastro resistant tablet
janssen-cilag international nv (0000003494) turnhoutseweg 30, beerse, b-2340 - rabeprazole sodium - gastro resistant tablet - 20mg - rabeprazole sodium (8000001712) 20mg - rabeprazole
pariet 10mg gastro resistant tablet
janssen-cilag international nv (0000003494) turnhoutseweg 30, beerse, b-2340 - rabeprazole sodium - gastro resistant tablet - 10mg - rabeprazole sodium (8000001712) 10mg - rabeprazole
venofer 100mg/5ml solution for injection
the star medicines importers co. ltd (0000003109) 10 loukis akritas str, lemesos, 3601, 50151 - saccharated iron oxide - solution for injection - 100mg/5ml - saccharated iron oxide (0008047674) 100mg - saccharated iron oxide
nevalan 40mg gastro resistant tablet
remedica ltd (0000003171) aharnon str., lemesos, 3056 - esomeprazole magnesium dihydrate - gastro resistant tablet - 40mg - esomeprazole magnesium dihydrate (8000003978) 43.38mg - esomeprazole
nevalan 20mg gastro resistant tablet
remedica ltd (0000003171) aharnon str., lemesos, 3056 - esomeprazole magnesium dihydrate - gastro resistant tablet - 20mg - esomeprazole magnesium dihydrate (8000003978) 21.69mg - esomeprazole
doxorubicin-ebewe 2mg/ml solution for infusion, concentrate for
t.c.christoforou ltd - ΔΟΞΟΡΟΥΒΙΚΊΝΗ - solution for infusion, concentrate for - 2mg/ml - 0023214928 - doxorubicin - 2 mg - doxorubicin
rasilez
noden pharma dac - αλισκιρένη - Υπέρταση - Παράγοντες που δρουν στο σύστημα ρενίνης-αγγειοτενσίνης - Θεραπεία της ιδιοπαθούς υπέρτασης.
minaxen 50mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - minocycline hydrochloride - capsule,hard - 50mg - minocycline hydrochloride (0013614987) 53,98mg - minocycline
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - Αντινεοπλασματικοί παράγοντες - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.